Category: Treatment


Clinical Trials to Watch: Turning Cold Tumors Hot

By Kristen Mueller, PhD | 15 May 2019 In Science, Treatment

We know that the billions of bacteria that live in our bodies can impact the way we respond to immunotherapy, but can we harness this help more patients respond these life-saving drugs?

Read More


Melanoma Vaccines Show Promise

14 April 2019 In Science, Treatment

While immunotherapy has transformed way melanoma is treated, about half of patients still do not respond. Researchers are pursuing multiple strategies to understand why this happens and to develop strategies to jumpstart a response. One approach showing promise in early clinical trials, comes in the form of new personalized vaccines being developed by Ugur Sahin of Johannes Gutenberg-Universität Mainz and BioNTech.

Read More


What’s Next for the Microbiome in Melanoma?

By Kristen Mueller, PhD | 11 April 2019 In Science, Treatment

We know that the billions of bacteria that live in our bodies can impact the way we respond to immunotherapy, but can we harness this help more patients respond these life-saving drugs?

Read More


Overcoming Targeted Therapy Resistance

By Marc Hurlbert, PhD, MRA Chief Executive Officer | 22 February 2019 In Science, Treatment

Targeted therapies work well for many patients, but most will go on to develop acquired resistance. Researchers are working to address this challenge. Learn about two promising examples.

Read More


Unchartered Territory: When Should Patients Stop Immunotherapy?

By Cody Barnett, MPH, MRA Director of Communications & Patient Engagement | 23 January 2019 In Melanoma Stories, Science, Treatment

For melanoma patients, deciding when to discontinue treatment is a difficult decision. should the general ‘rule of thumb’ of treating patients with advanced disease until progression still apply? According to Dr. Jeffrey Weber and the data he presented at the European Society for Medical Oncology (ESMO) Congress late last year, the answer is maybe not.

Read More


Melanoma Treatment Advances – 2018 in Review

By Marc Hurlbert, PhD, MRA Chief Executive Officer | 18 January 2019 In Science, Treatment

2018 brought new and expanded drug approvals that give patients, doctors, and their families more treatment options with fewer side effects. Learn more about important melanoma treatment advances in 2018.

Read More


MRA Advisor & Grantee Dr. Allison Awarded Nobel Prize for Transforming Cancer Care

By Cody Barnett, MPH, MRA Director of Communications & Patient Engagement | 28 November 2018 In News, Science, Treatment

MRA Scientific Advisory Panel Member & Grantee Dr. Allison Awarded Nobel Prize for his pioneering research to harness the power of the immune system to attack cancer. His work in immunotherapy, which began in the 1990’s, was audacious at the time. It helped to mainstream an entirely new class of tools in the arsenal against cancer; joining the likes of chemotherapy, radiation, and surgery.

Read More


Older Patients Do Better on Immunotherapy

By Cody Barnett, MPH, MRA Director of Communications & Patient Engagement | 8 October 2018 In Science, Treatment

In Dr. Weeraratna's study, older patients did better on immunotherapy than younger patients. This surprising result is the opposite of what was expected.

Read More


Right Place, Right Time, Right Trial

10 September 2018 In Melanoma Stories, Treatment

Jonathan is cancer free because he was in the right place at the right time to be enrolled in a clinical trial. Read his story.

Read More


Maintaining the Pace of Melanoma Innovation in the Era of an Evolving Standard of Care

10 August 2018 In Science, Treatment

There is no doubt that treatments for metastatic melanoma have changed dramatically in the decade since MRA’s founding in 2007. How do we keep up the momentum?

Read More


Login

×